328 related articles for article (PubMed ID: 22753758)
21. Standard treatment and experimental targeted drug therapy for recurrent glioblastoma multiforme.
Chang SM; Butowski NA; Sneed PK; Garner IV
Neurosurg Focus; 2006 Apr; 20(4):E4. PubMed ID: 16709035
[TBL] [Abstract][Full Text] [Related]
22. Molecular advances of brain tumors in radiation oncology.
Noda SE; El-Jawahri A; Patel D; Lautenschlaeger T; Siedow M; Chakravarti A
Semin Radiat Oncol; 2009 Jul; 19(3):171-8. PubMed ID: 19464632
[TBL] [Abstract][Full Text] [Related]
23. Novel approaches and mechanisms of immunotherapy for glioblastoma.
Hegde M; Bielamowicz KJ; Ahmed N
Discov Med; 2014 Mar; 17(93):145-54. PubMed ID: 24641957
[TBL] [Abstract][Full Text] [Related]
24. Targeting cancer stem cells for treatment of glioblastoma multiforme.
Cho DY; Lin SZ; Yang WK; Lee HC; Hsu DM; Lin HL; Chen CC; Liu CL; Lee WY; Ho LH
Cell Transplant; 2013; 22(4):731-9. PubMed ID: 23594862
[TBL] [Abstract][Full Text] [Related]
25. Delivery systems and molecular targets of mechanism-based therapies for GBM.
Phuphanich S; Brat DJ; Olson JJ
Expert Rev Neurother; 2004 Jul; 4(4):649-63. PubMed ID: 15853584
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic therapies in glioblastoma multiforme.
McNamara MG; Mason WP
Expert Rev Anticancer Ther; 2012 May; 12(5):643-54. PubMed ID: 22594899
[TBL] [Abstract][Full Text] [Related]
27. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.
Drabycz S; Roldán G; de Robles P; Adler D; McIntyre JB; Magliocco AM; Cairncross JG; Mitchell JR
Neuroimage; 2010 Jan; 49(2):1398-405. PubMed ID: 19796694
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
Felsberg J; Rapp M; Loeser S; Fimmers R; Stummer W; Goeppert M; Steiger HJ; Friedensdorf B; Reifenberger G; Sabel MC
Clin Cancer Res; 2009 Nov; 15(21):6683-93. PubMed ID: 19861461
[TBL] [Abstract][Full Text] [Related]
29. [What's next in glioblastoma treatment: Tumor-targeted or immune-targeted therapies?].
Schernberg A; Marabelle A; Massard C; Armand JP; Dumont S; Deutsch E; Dhermain F
Bull Cancer; 2016 May; 103(5):484-98. PubMed ID: 27032303
[TBL] [Abstract][Full Text] [Related]
30. Biomarkers and therapeutic advances in glioblastoma multiforme.
Sasmita AO; Wong YP; Ling APK
Asia Pac J Clin Oncol; 2018 Feb; 14(1):40-51. PubMed ID: 28840962
[TBL] [Abstract][Full Text] [Related]
31. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract][Full Text] [Related]
32. [Chemotherapy and targeted treatments in glioblastomas].
Chinot O; Soulier P; Frenay M
Neurochirurgie; 2010 Dec; 56(6):491-8. PubMed ID: 21035151
[TBL] [Abstract][Full Text] [Related]
33. Molecular pathways and potential therapeutic targets in glioblastoma multiforme.
Wardak Z; Choe KS
Expert Rev Anticancer Ther; 2013 Nov; 13(11):1307-18. PubMed ID: 24168050
[TBL] [Abstract][Full Text] [Related]
34. Different T-cell subsets in glioblastoma multiforme and targeted immunotherapy.
Wang H; Zhou H; Xu J; Lu Y; Ji X; Yao Y; Chao H; Zhang J; Zhang X; Yao S; Wu Y; Wan J
Cancer Lett; 2021 Jan; 496():134-143. PubMed ID: 33022290
[TBL] [Abstract][Full Text] [Related]
35. Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies.
Agnihotri S; Burrell KE; Wolf A; Jalali S; Hawkins C; Rutka JT; Zadeh G
Arch Immunol Ther Exp (Warsz); 2013 Feb; 61(1):25-41. PubMed ID: 23224339
[TBL] [Abstract][Full Text] [Related]
36. Glioblastoma multiforme: Pathogenesis and treatment.
Alifieris C; Trafalis DT
Pharmacol Ther; 2015 Aug; 152():63-82. PubMed ID: 25944528
[TBL] [Abstract][Full Text] [Related]
37. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
[TBL] [Abstract][Full Text] [Related]
38. Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors.
Chan JK; Lam PY
Cancer Gene Ther; 2013 Oct; 20(10):539-43. PubMed ID: 24052128
[TBL] [Abstract][Full Text] [Related]
39. Standards of care and novel approaches in the management of glioblastoma multiforme.
Hottinger AF; Stupp R; Homicsko K
Chin J Cancer; 2014 Jan; 33(1):32-9. PubMed ID: 24384238
[TBL] [Abstract][Full Text] [Related]
40. Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond.
Daisy Precilla S; Kuduvalli SS; Thirugnanasambandhar Sivasubramanian A
Cell Biol Int; 2021 Jan; 45(1):18-53. PubMed ID: 33049091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]